Innovation1 Biotech Appoints Frederick E. Pierce, II to its Board of Directors
September 15, 2022 12:00 ET
|
Innovation1 Biotech Inc.
NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1'' or the “Company”), a small molecule drug discovery company focused on the clinical development of...
Innovation1 Biotech Announces Filing of Patent Application for Novel Combination Therapy Targeting Addiction
August 18, 2022 07:30 ET
|
Innovation1 Biotech Inc.
NEW YORK, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1'' or the “Company”), a small molecule drug discovery company focused on the clinical development of...
Innovation1 Biotech Appoints Chief Scientific Officer Andrew L. Salzman, M.D. to its Board of Directors
August 11, 2022 07:30 ET
|
Innovation1 Biotech, Inc.
NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1” or the “Company”), a small molecule drug discovery company focused on the clinical development of...
Innovation1 Biotech (IVBT) Completes Name and Ticker Symbol Change from Gridiron BioNutrients (GMVP)
April 04, 2022 07:30 ET
|
Innovation1 Biotech, Inc.
NEW YORK, April 04, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1” or the “Company”), a small molecule drug discovery company focused on the clinical development of...